Clinical Trials Browser

Phase 1 × Neoplasm Metastasis × Tablets × Clear all

NCT01976741 2021-05-06

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Phase 1 Completed

168 enrolled 59 charts

GenitourinaryHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00667485 2014-01-17

Rapamycin Plus Bevacizumab in Advanced Cancers

Phase 1 Completed

Neoplasm Metastasis